SUPERNUS PHARMACEUTICALS, INC.·4

Feb 25, 5:24 PM ET

SIEBERT JOHN M 4

4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 25, 2020

Insider Transaction Report

Form 4
Period: 2020-02-21
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2020-02-21+9,3059,305 total
    Exercise: $23.99From: 2021-02-21Exp: 2030-02-21Common Stock (9,305 underlying)
  • Award

    Common Stock

    2020-02-21$23.99/sh+5,211$125,01260,953 total
Footnotes (1)
  • [F1]Represents restricted stock unit component of the annual equity compensation to directors. These shares will be settled in common stock upon vesting, such vesting to occur on February 21, 2021. Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.

Documents

1 file
  • 4
    a4.xmlPrimary

    4